Selected article for: "cc ND international license and mortality morbidity"
Author: Joseph P Dudley; Nam Taek Lee
Title: Disparities in Age-Specific Morbidity and Mortality from SARS-CoV-2 in China and the Republic of Korea
  • Document date: 2020_3_27
    • ID: 9t0rbgjb_15
    Snippet: Pandemic in the Republic of Korea (ROK) and China. Closer study of the factors underlying the initiation and early proliferation of the SARS-CoV-2 epidemics in China and the ROK may provide valuable insights . CC-BY-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The available epidemiological and observational data from the ROK suggests that reduced .....
    Document: Pandemic in the Republic of Korea (ROK) and China. Closer study of the factors underlying the initiation and early proliferation of the SARS-CoV-2 epidemics in China and the ROK may provide valuable insights . CC-BY-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The available epidemiological and observational data from the ROK suggests that reduced rates of compliance with social distancing and self-quarantine recommendations among different sectors of the population -especially the younger adult and juvenile age cohorts --may have a significant impact on the age-specific rates of morbidity and mortality within the population as a whole.

    Search related documents:
    Co phrase search for related documents
    • age cohort and international license: 1, 2, 3, 4, 5, 6
    • age cohort and mortality morbidity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • age cohort and population mortality morbidity: 1, 2, 3
    • age specific rate and cc ND international license: 1
    • age specific rate and international license: 1, 2, 3
    • age specific rate and mortality morbidity: 1, 2, 3, 4
    • age specific rate and reduce rate: 1, 2
    • cc ND international license and China SARS epidemic: 1
    • cc ND international license and close study: 1
    • cc ND international license and international license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cc ND international license and mortality morbidity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • cc ND international license and reduce rate: 1, 2, 3, 4, 5, 6, 7
    • China SARS epidemic and international license: 1, 2
    • China SARS epidemic and mortality morbidity: 1, 2, 3
    • China SARS epidemic and reduce rate: 1
    • close study and international license: 1, 2
    • close study and mortality morbidity: 1, 2
    • compliance reduce rate and mortality morbidity: 1
    • compliance reduce rate and reduce rate: 1, 2